According to the new market research report “Bone Growth Stimulator Market by Product (Device, Bone morphogenetic protein, PRP), Application (spinal fusion, Delayed Union & Non Union Bone Fracture, Dental, Maxillofacial), End User (Hospitals, Homecare, Academia, CROs) — Global Forecast” , published by MarketsandMarkets™, The Bone Growth Stimulator Market is expected to reach USD 1.41 billion, at a CAGR of 5.4%.
On the basis of product, the global bone growth stimulator market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The bone growth stimulation devices segment accounted for the largest share of the market.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=82341383
On the basis of application, the global bone growth stimulator market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, oral and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment accounted for the largest share of the market.
Browse and in-depth TOC on “Bone Growth Stimulator Market”
66 — Tables
67 — Figures
153 — Pages
On the basis of region, this bone growth stimulator market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. The global bone growth stimulator market was dominated by North America mainly due to the growing elderly population, increasing the incidence of arthritis and sports injuries, adoption of novel treatment options, and rising demand for minimally invasive spinal surgeries.
Read a Press-Release on “Bone Growth Stimulator Market”:
https://www.marketsandmarkets.com/PressReleases/bone-growth-stimulators.asp
The Asia-Pacific market is expected to grow at the highest CAGR. This is primarily due to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), raising awareness among healthcare professionals related to novel and upcoming treatment options, and ongoing government initiatives to modernize & expand healthcare infrastructure.
Orthofix International N.V. (U.S.), DJO Finance LLC (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Bioventus LLC (U.S.), Medtronic plc (Ireland), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), and Harvest Technologies Corporation (U.S.) are some of the key players in the bone growth stimulator market.
